Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens. [electronic resource]
Producer: 20040430Description: 1-6 p. digitalISSN:- 1087-2914
- Adult
- Antiretroviral Therapy, Highly Active -- methods
- Area Under Curve
- CD4 Lymphocyte Count
- Carbamates
- Drug Administration Schedule
- Drug Resistance, Viral
- Female
- Furans
- Genotype
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- blood
- HIV-1 -- drug effects
- Humans
- Lopinavir
- Male
- Mutation -- drug effects
- Patient Selection
- Phenotype
- Predictive Value of Tests
- Prospective Studies
- Pyrimidinones -- therapeutic use
- RNA, Viral -- blood
- Ritonavir -- blood
- Salvage Therapy -- methods
- Sulfonamides -- blood
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.